의료진
의료진소개
배영경
- [진료과] 병리과
- [주연구분야] 유전자발현 양상에 따른 유방암의 예후인자
- [직위] 교수
- [진료과목] 유방병리, 피부병리
진료예약
| 의사 | 진료과목 | 구분 | 월 | 화 | 수 | 목 | 금 | 토 | 예약 |
|---|---|---|---|---|---|---|---|---|---|
| 배영경 | 유방병리, 피부병리 | 오전 | 진료예약 | ||||||
| 오후 |
학력
1993. 02 영남대학교 의과대학 졸업
1997. 02 영남대학교 대학원 의학석사
2000. 08 영남대학교 대학원 의학박사
2001~2002 Johns Hopkins School of Medicine, Postdoctoral fellowship
1997. 02 영남대학교 대학원 의학석사
2000. 08 영남대학교 대학원 의학박사
2001~2002 Johns Hopkins School of Medicine, Postdoctoral fellowship
경력
1993. 03 ~ 1994. 02 영남대학교병원 인턴
1994. 03 ~ 1998. 02 영남대학교병원 병리과 전공의
2003. 03 ~ 2014. 02 영남대학교 의과대학 전임강사, 조교수, 부교수
2014. 03 ~ 현재 영남대학교 의과대학 교수
1994. 03 ~ 1998. 02 영남대학교병원 병리과 전공의
2003. 03 ~ 2014. 02 영남대학교 의과대학 전임강사, 조교수, 부교수
2014. 03 ~ 현재 영남대학교 의과대학 교수
학회 및 대외활동
[학회활동]
대한병리학회, 대한세포병리학회, 한국유방암학회, 대한암학회, 미국캐나다병리학회 정회원
대한병리학회/대한세포병리학회 편집위원
대한세포병리학회 지도의/자격인정위원
[발표논문-주저자]
Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer. Kim MC, Kwon SY, Jung HR, Bae YK. Virchows Arch. 2024 Dec;485(6):1117-1125.
A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols. Kim MC, Cho EY, Park SY, Lee HJ, Lee JS, Kim JY, Lee HC, Yoo JY, Kim HS, Kim B, Kim WS, Shin N, Maeng YH, Kim HS, Kwon SY, Kim C, Jun SY, Kwon GY, Choi HJ, Lee SM, Choi JE, An AR, Choi HJ, Kim E, Kim A, Kim JY, Shim JY, Gong G, Bae YK. Cancer Res Treat. 2024 Oct;56(4):1096-1104.
Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. Kim MC, Kwon SY, Choi JE, Kang SH, Bae YK. J Breast Cancer. 2023 Apr;26(2):105-116.
Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer. Kim MC, Park MH, Choi JE, Kang SH,Bae YK. J Breast Cancer. 2022 Aug;25(4):318-326.
Immunohistochemical s of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer. Park MH, Choi JE, Kim JR, Bae YK. Pathol Oncol Res. 2021 Jun 29;27:1609795.
Clinicopathologic features of cutaneous stases from internal malignancies. Kwon HM, Kim GY, Shin DH, Bae YK. J Pathol Transl Med. 2021 Jul;55(4):289-297.
Standardized Pathology Report for Breast Cancer. Cho SY, Park SY, Bae YK, Kim JY, Kim EK, Kim WG, Kwon Y, Lee A, Lee HJ, Lee JS, Park JY, Gong G, Yoon HK. J Breast Cancer. 2021 Feb;24(1):1-21.
Intratumoral CD103-positive Tumor-Infiltrating Lymphocytes Are Associated With Favorable Prognosis in Patients With Triple-Negative Breast Cancer. Park MH, Kwon SY, Choi JE, Gong G, Bae YK. Histopathology. 2020 Oct;77(4):560-569.
High Mobility Group A1 (HMGA1) Protein and Gene Correlate With ER-negativity and Poor Outcomes in Breast Cancer. Gorbounov M, Carleton NM, Asch-Kendrick RJ, Xian L, Rooper L, Chia L, Cimino-Mathews A, Cope L, Meeker A, Stearns V, Veltri RW, Bae YK*, Resar LMS*. (*co-corresponding) Breast Cancer Res Treat. 2020;179(1):25-35.
대한병리학회, 대한세포병리학회, 한국유방암학회, 대한암학회, 미국캐나다병리학회 정회원
대한병리학회/대한세포병리학회 편집위원
대한세포병리학회 지도의/자격인정위원
[발표논문-주저자]
Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer. Kim MC, Kwon SY, Jung HR, Bae YK. Virchows Arch. 2024 Dec;485(6):1117-1125.
A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols. Kim MC, Cho EY, Park SY, Lee HJ, Lee JS, Kim JY, Lee HC, Yoo JY, Kim HS, Kim B, Kim WS, Shin N, Maeng YH, Kim HS, Kwon SY, Kim C, Jun SY, Kwon GY, Choi HJ, Lee SM, Choi JE, An AR, Choi HJ, Kim E, Kim A, Kim JY, Shim JY, Gong G, Bae YK. Cancer Res Treat. 2024 Oct;56(4):1096-1104.
Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. Kim MC, Kwon SY, Choi JE, Kang SH, Bae YK. J Breast Cancer. 2023 Apr;26(2):105-116.
Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer. Kim MC, Park MH, Choi JE, Kang SH,Bae YK. J Breast Cancer. 2022 Aug;25(4):318-326.
Immunohistochemical s of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer. Park MH, Choi JE, Kim JR, Bae YK. Pathol Oncol Res. 2021 Jun 29;27:1609795.
Clinicopathologic features of cutaneous stases from internal malignancies. Kwon HM, Kim GY, Shin DH, Bae YK. J Pathol Transl Med. 2021 Jul;55(4):289-297.
Standardized Pathology Report for Breast Cancer. Cho SY, Park SY, Bae YK, Kim JY, Kim EK, Kim WG, Kwon Y, Lee A, Lee HJ, Lee JS, Park JY, Gong G, Yoon HK. J Breast Cancer. 2021 Feb;24(1):1-21.
Intratumoral CD103-positive Tumor-Infiltrating Lymphocytes Are Associated With Favorable Prognosis in Patients With Triple-Negative Breast Cancer. Park MH, Kwon SY, Choi JE, Gong G, Bae YK. Histopathology. 2020 Oct;77(4):560-569.
High Mobility Group A1 (HMGA1) Protein and Gene Correlate With ER-negativity and Poor Outcomes in Breast Cancer. Gorbounov M, Carleton NM, Asch-Kendrick RJ, Xian L, Rooper L, Chia L, Cimino-Mathews A, Cope L, Meeker A, Stearns V, Veltri RW, Bae YK*, Resar LMS*. (*co-corresponding) Breast Cancer Res Treat. 2020;179(1):25-35.
수상경력
2025 대한암학회 우수논문상, 한국과총 과학기술우수논문상
2018 한국유방암학회 우수논문상 (Best paper award)
2012 한국유방암학회 우수논문상 (Best paper award)
2012 영남의대 우수연구교수
2010 한국유방암학회 학술상 (우수연제상)
2009 한국유방암학회 동아학술상 (우수논문상)
2018 한국유방암학회 우수논문상 (Best paper award)
2012 한국유방암학회 우수논문상 (Best paper award)
2012 영남의대 우수연구교수
2010 한국유방암학회 학술상 (우수연제상)
2009 한국유방암학회 동아학술상 (우수논문상)
연수
2006.09 ~ 2007.08 미국 존스홉킨스병원 병리과 연수 (visiting scholar)